Konopke Ralf, Kersting Stephan, Makowiec Frank, Gassmann Peter, Kuhlisch Eberhard, Senninger Norbert, Hopt Ulrich, Saeger Hans Detlev
Department of General, Thoracic and Vascular Surgery, University of Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
World J Surg. 2008 Sep;32(9):2047-56. doi: 10.1007/s00268-008-9629-2.
A safety margin of > or =10 mm is generally accepted in surgery for colorectal metastases. It is reasonable that modern methods of liver parenchyma dissection may allow for a reduction in this distance.
A total of 333 patients were included in a multicenter trial after resection of colorectal liver metastases. Dissection of the liver had been performed with a CUSA, UltraCision, or water-jet dissector. The size of the resection margin was correlated with recurrence risk and survival.
The median hepatic recurrence-free survival reached 35 months for all patients; median recurrence-free survival was 24 months and overall survival was 41 months. Univariate analysis of different groups denoting the extent of resection margin (> or =10 mm, 6-9 mm, 3-5 mm, 1-2 mm, 0 mm (R1)) indicated that a margin of 1-2 mm leads to a significantly reduced median hepatic recurrence-free survival of 20 months (p = 0.004) and recurrence-free survival of 19 months (p = 0.011). Patients with R1 resection had the worst prognosis. Overall survival was not influenced by the size of the resection margin. Surgical margins were significantly reduced in simultaneous resections of four or more liver metastases and in cases in which metastatic infiltration of central liver segments was present. At multivariate analysis, resection margins of 1-2 mm and 0 mm were independent predictors of hepatic recurrence and overall recurrence.
The indication for resection of metastases can be safely extended to cases in which tumors sit closer than 1 cm to nonresectable structures.
在结直肠癌肝转移手术中,通常认为切缘≥10 mm 是安全切缘。现代肝实质离断方法有可能缩短这一切缘距离,这是合理的。
一项多中心试验纳入了 333 例结直肠癌肝转移切除术后的患者。肝脏离断采用了超声外科吸引器(CUSA)、超声刀(UltraCision)或水刀分离器。切缘大小与复发风险和生存率相关。
所有患者的肝无复发生存期(RFS)中位数达 35 个月;无复发生存期中位数为 24 个月,总生存期为 41 个月。对表示切缘范围(≥10 mm、6 - 9 mm、3 - 5 mm、1 - 2 mm、0 mm(R1))的不同组进行单因素分析表明,1 - 2 mm 的切缘会导致肝无复发生存期中位数显著缩短至 20 个月(p = 0.004),无复发生存期为 19 个月(p = 0.011)。R1 切除的患者预后最差。总生存期不受切缘大小的影响。在同时切除 4 个或更多肝转移灶以及存在肝中央段转移浸润的病例中,手术切缘显著缩小。多因素分析显示,1 - 2 mm 和 0 mm 的切缘是肝复发和总体复发的独立预测因素。
转移灶切除术的适应证可安全地扩大到肿瘤距不可切除结构小于 1 cm 的病例。